Finland · Delayed Price · Currency is EUR Glaston Oyj Abp Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw lower net sales and order intake amid global uncertainty, but EBITDA margin and cash flow improved due to accelerated cost savings and a strong service business. Outlook for 2026 remains cautious, with further declines in sales and EBITDA expected.
Fiscal Year 2025
-
Order intake in Q4 2025 was the year's strongest, but full-year sales and profitability declined amid ongoing market softness. No dividend will be paid, and 2026 is expected to see further decreases in net sales and EBITDA.
-
Q2 saw a 24% drop in order intake and modest 4% net sales growth, with profitability pressured by market headwinds and one-off costs. Cost-saving measures and a strong backlog support confidence in a stronger second half, though full-year guidance is lower than last year.
-
Q2 saw a 24% drop in order intake and a 4% rise in net sales, with profitability pressured by market headwinds. A cost reduction program and strong backlog support confidence in meeting revised 2025 guidance, despite ongoing uncertainty in key segments.
-
Q1 2025 saw stable results amid soft markets, with order intake up 1% and net sales down 7% year-over-year. Outlook for 2025 remains unchanged, with net sales and EBITDA expected to stay at or above last year's level, despite ongoing tariff-related uncertainties.
Fiscal Year 2024
-
Order intake declined 8% year-over-year amid soft markets, but EBITDA margin improved slightly to 7% for the year. Production transfer to China and cost actions are expected to drive profitability gains, especially in the second half of 2025.
-
Q3 2024 delivered solid results with 4% sales growth and a 7.5% EBITDA margin, driven by strong performance in mobility, display, and solar technologies, especially in China. Strategic focus shifts to services and global operations, with organizational restructuring set for January 2025.
-
Profitability in Q2 2024 was driven by strong service growth, offsetting market softness and a 10% decline in net sales. Major production transfer to China will bring significant one-off costs in H2, while 2024 EBITDA is guided at €14.5–16 million.